Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD.

Sun X, Jefferson P, Zhou Q, Angelastro JM, Greene LA
Mol Cancer Res. 2020 Feb;18(2):216-228. doi: 10.1158/1541-7786.MCR-19-0631. Epub 2019 Nov 1. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.